PharmatrophiX is a clinical-stage biopharmaceutical company focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases, advancing a pipeline of small-molecule drugs targeting p75, TrkB, and TrkC receptors
PharmatrophiX is a clinical-stage biopharmaceutical company focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases, advancing a pipeline of small-molecule drugs targeting p75, TrkB, and TrkC receptors.